Coral Drugs Private Limited, a active private limited company, was established on 22 December 1993 in New Delhi, Delhi, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U74899DL1993PTC056582. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹9.00 M and a paid-up capital of ₹4.24 M.
Formerly known as Coral Tex Knit Private Limited. It upholds a compliant status. Its leadership includes Pawan Kumar Agarwal (Director), Ravi Pratap Srivastava (Whole-Time Director), Meena Bhuwania (Whole-Time Director). Past directors included Shyam Sunder Sharma, Rakesh Kumar Nigam, Pawan Kumar Agarwal. It holds ₹11.35 Cr open charges and ₹38.05 Cr settled loans. Its latest AGM occurred on 04 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1001 Akash Deep Building, 26-A, Barakhamba Road, New Delhi, Delhi, 110001.
U74899DL1993PTC056582
056582
22 December 1993
₹9.00 M
₹4.24 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Coral Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pawan Kumar Agarwal | Director | 15 Jan 2024 | Current |
| Ravi Pratap Srivastava | Whole-Time Director | 20 Sep 2023 | Current |
| Meena Bhuwania | Whole-Time Director | 01 Dec 1998 | Current |
| Binay Kumar Bhuwania | Whole-Time Director | 22 Dec 1993 | Current |
| Rohit Bhuwania | Managing Director | 07 Nov 2002 | Current |
| Neeraj Ramesh Lal Mankani | Additional Director | 20 Jan 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 22 Oct 2010 | Past |
| Pramod Abcsdd | Whole-Time Director | 18 Apr 2009 | Past |
| Pramod Abcsdd | Additional Director | 03 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 20 Sep 2023 | Past |
| Pramod Abcsdd | Whole-Time Director | 31 Mar 2016 | Past |
| Pramod Abcsdd | Director | 27 May 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Coral Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.16% increase. The company also saw a substantial improvement in profitability, with a 23% increase in profit. The company's net worth Soared by an impressive increase of 14.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Coral Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹113,512,685.00
₹380,519,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Feb 2021 | Hdfc Bank Limited | ₹7.00 Cr | Open |
| 29 Nov 2017 | Others | ₹5.21 M | Open |
| 01 Sep 2017 | Bank Of India | ₹3.23 Cr | Open |
| 15 Mar 2013 | Pnb Housing Finance Limited | ₹6.00 M | Open |
| 28 Feb 2015 | Bank Of India | ₹3.40 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Coral Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Coral Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Coral Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Neeraj Ramesh Lal Mankani was appointed as a Additional Director was appointed as a Additional Director on 20 Jan 2025 & has been associated with this company since 10 months 10 days . was recorded as a recent event.
Progress on Coral Drugs Private Limited last Annual general meeting of members was held on 04 Sep 2024 as per latest MCA records. was documented.
Progress on Coral Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on Pawan Kumar Agarwal was appointed as a Director was appointed as a Director on 15 Jan 2024 & has been associated with this company since 1 year 10 months . was documented.
The activity A charge with Bank Of India of Rs. 32.30 M registered on 01 Sep 2017 with Charge ID 100124673 was modified on 04 Jan 2024. was completed.
The activity Ravi Pratap Srivastava was appointed as a Whole-time director was appointed as a Whole-time director on 20 Sep 2023 & has been associated with this company since 2 years 2 months . was completed.
The CIN of Coral Drugs Private Limited is U74899DL1993PTC056582.
Coral Drugs Private Limited is headquartered at 1001 Akash Deep Building, 26-A, Barakhamba Road, New Delhi, Delhi, 110001.
Coral Drugs Private Limited was incorporated on 22 December 1993.
The current directors of Coral Drugs Private Limited are
The primary industry of Coral Drugs Private Limited is Manufacturing.
Coral Drugs Private Limited is unlisted.
The authorized capital of Coral Drugs Private Limited is ₹9.00 M, and the paid-up capital is ₹4.24 M.
The compliance status of Coral Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX